Legend Biotech Corp
NASDAQ:LEGN
Legend Biotech Corp
NASDAQ:LEGN
Price:
40.03 USD
0.05%
Updated:
Jun 4, 2024
Legend Biotech Corp
Other Current Liabilities
|
Legend Biotech Corp
Other Current Liabilities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Legend Biotech Corp
NASDAQ:LEGN
|
Other Current Liabilities
$90.6m
|
CAGR 3-Years
33%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Liabilities
$3.3B
|
CAGR 3-Years
149%
|
CAGR 5-Years
406%
|
CAGR 10-Years
26%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Liabilities
$648.6m
|
CAGR 3-Years
32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
27%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Liabilities
$516.7m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
23%
|
See Also
What is Legend Biotech Corp's Other Current Liabilities?
Other Current Liabilities
90.6m
USD
90.6m
USD
Based on the financial report for Dec 31, 2023, Legend Biotech Corp's Other Current Liabilities amounts to 90.6m USD.
What is Legend Biotech Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-5%
-5%
Over the last year, the Other Current Liabilities growth was -19%. The average annual Other Current Liabilities growth rates for Legend Biotech Corp have been 33% over the past three years , -5% over the past five years .
You don't have any saved screeners yet
